What is the most recent public date tied to reaching or confirming the highest us phase for absorica (isotretinoin by sun pharmaceuticals)?

I’m afraid I can’t find any publicly disclosed confirmation that Absorica (Sun Pharmaceutical’s isotretinoin product) has entered a U.S. Phase 3 or higher clinical trial. The most recent public record I can locate is the company’s submission of a New Drug Application (NDA) to the FDA in 2019, which does not yet reflect a post‑approval (“Phase 4”) status. In short, there is no publicly documented date that marks Absorica as having reached a higher U.S. phase beyond pre‑clinical or early‑clinical development.

If you need the absolute latest status, I recommend checking the FDA’s CDER database or the most recent investor presentation or press release issued by Sun Pharmaceuticals, as those sources are updated as new milestones are achieved.